Key takeaways
- • Severity: No clinically significant interaction known.
- • Ozempic (type 2 diabetes (FDA-approved T2D)) and Empagliflozin (Jardiance) (SGLT2 inhibitor (diabetes/CV)).
- • Clinical management: Routinely combined; no interaction-driven dose adjustment. Hydration status and volume depletion are managed per usual SGLT2 practice.
- • Monitoring: Standard diabetes, renal, and volume monitoring.
Mechanism
SGLT2 inhibitors and GLP-1 receptor agonists work through independent mechanisms (urinary glucose excretion vs. incretin signaling) and are commonly combined for additive glycemic, cardiovascular, and renal benefit. No clinically significant pharmacokinetic interaction has been documented.
Clinical management
Routinely combined; no interaction-driven dose adjustment. Hydration status and volume depletion are managed per usual SGLT2 practice.
GLP1Zoom does not prescribe medications or recommend dose changes. Always confirm any adjustment with your prescribing clinician before changing how you take Ozempic or Empagliflozin (Jardiance).
Monitoring
Standard diabetes, renal, and volume monitoring.
When to call your doctor
- signs of dehydration
- symptoms suggestive of DKA (rare)
In emergencies — severe abdominal pain, persistent vomiting, fainting, signs of severe hypoglycemia (confusion, seizures), or signs of bleeding — call 911 or go to the nearest emergency department.
Source / FDA label citation
Not specifically listed in current FDA label as an interaction.
Editorial confidence: 9/10. Lower scores reflect inferred mechanism rather than directly-labeled interaction. We re-verify against the active FDA prescribing information at least every 6 months.
Common questions
Can I take Empagliflozin (Jardiance) with Ozempic?
Empagliflozin (Jardiance) and Ozempic have no clinically significant interaction documented. Standard prescribing applies. Always confirm with your prescriber, since individual medical history can change the calculation.
What's the mechanism of any Ozempic + Empagliflozin (Jardiance) interaction?
SGLT2 inhibitors and GLP-1 receptor agonists work through independent mechanisms (urinary glucose excretion vs. incretin signaling) and are commonly combined for additive glycemic, cardiovascular, and renal benefit. No clinically significant pharmacokinetic interaction has been documented.
What should I monitor when on Ozempic + Empagliflozin (Jardiance)?
Standard diabetes, renal, and volume monitoring.
When should I call my doctor?
Contact your prescriber if you notice any of: signs of dehydration; symptoms suggestive of DKA (rare).
Related
This page summarizes general pharmacology from FDA-approved prescribing information. It is not a substitute for personalized medical advice. GLP1Zoom is an affiliate-only comparator — we do not prescribe or sell medications. Full disclaimer.